Company Number: 12542632

Analysis Date: 2025-07-20 15:47 UTC

1. Risk Rating: HIGH
   Justification: The company shows minimal financial activity with consistently nominal net assets (£1,000) over multiple years and no fixed assets or recorded liabilities. The lack of growth or operational scale, combined with a single employee and micro-entity status, indicates significant risk regarding sustainability and solvency.

2. Key Concerns:

   • Financial Stasis: Net assets have remained static at £1,000 for four consecutive years, with no evidence of revenue generation or asset accumulation.
   • Operational Scale: The company employs only one person (the director), indicating limited operational capacity and potential challenges in sustaining business activities.
   • Director Profile & Control: The sole director is a student with a significant ownership stake (50-75%) and voting rights, raising concerns about the professional management and governance experience necessary for business growth and compliance.

3. Positive Indicators:

   • Compliance: The company has filed accounts and confirmation statements on time with no overdue filings, indicating regulatory compliance.
   • No Liabilities: No current or long-term liabilities are reported, which minimizes immediate solvency pressures.
   • Clear Ownership Structure: The ownership and voting rights are well documented, showing transparency in control.

4. Due Diligence Notes:

   • Revenue and Profitability: Investigate whether the company generates any revenue or has any contracts, as financial statements lack any indication of trading activity.
   • Business Model Viability: Assess the viability of the AI pharmaceutical demand prediction service claimed on the website, including client base, pipeline, and technology readiness.
   • Director Competence & Background: Review the director’s experience, capacity to manage the business, and any potential conflicts or risks associated with a sole director who is a student.
   • Related Party Transactions: Examine if there are any transactions with related parties or external funding sources supporting the company.
   • Future Funding Plans: Explore whether there are plans for capital injection or business development to improve financial position.